Similar articles

• Crystal structure of Dengue virus NS3 protease in complex with a Bowman-Birk inhibitor: implications for flaviviral polyprotein processing and drug design.

  Murthy HM, Judge K, DeLucas L, Padmanabhan R. Murthy HM, et al. J Mol Biol. 2000 Aug 25;301(4):759-67. doi: 10.1006/jmbi.2000.3924. J Mol Biol. 2000. Retraction in: J Mol Biol. 2010 Apr 9;397(4):1119. doi: 10.1016/j.jmb.2010.01.069. PMID: 10966782 Retracted.
• Crystallization, characterization and measurement of MAD data on crystals of dengue virus NS3 serine protease complexed with mung-bean Bowman-Birk inhibitor.

  Krishna Murthy HM, Judge K, DeLucas L, Clum S, Padmanabhan R. Krishna Murthy HM, et al. Acta Crystallogr D Biol Crystallogr. 1999 Jul;55(Pt 7):1370-2. doi: 10.1107/s0907444999007064. Acta Crystallogr D Biol Crystallogr. 1999. Retraction in: Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):222. doi: 10.1107/S0907444910000259. PMID: 10393310 Retracted.
• Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus.

  Erbel P, Schiering N, D'Arcy A, Renatus M, Kroemer M, Lim SP, Yin Z, Keller TH, Vasudevan SG, Hommel U. Erbel P, et al. Nat Struct Mol Biol. 2006 Apr;13(4):372-3. doi: 10.1038/nsmb1073. Epub 2006 Mar 12. Nat Struct Mol Biol. 2006. PMID: 16532006
• Cancer prevention by protease inhibitors.

  Kennedy AR. Kennedy AR. Prev Med. 1993 Sep;22(5):796-811. doi: 10.1006/pmed.1993.1073. Prev Med. 1993. PMID: 8234219 Review.
• Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target.

  Lescar J, Luo D, Xu T, Sampath A, Lim SP, Canard B, Vasudevan SG. Lescar J, et al. Antiviral Res. 2008 Nov;80(2):94-101. doi: 10.1016/j.antiviral.2008.07.001. Epub 2008 Jul 30. Antiviral Res. 2008. PMID: 18674567 Review.